Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy-Reference-Cited by-同舟云学术

Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy

Published:2022-10 Issue:10 Volume:115 Page:529-537
ISSN:1875-2136
Container-title:Archives of Cardiovascular Diseases
language:en
Short-container-title:Archives of Cardiovascular Diseases

Author:

Iavarone Michele,Monda Emanuele,Vritz Olga,Calila Albert Dimpna,Rubino Marta,Verrillo Federica,Caiazza Martina,Lioncino Michele,Amodio Federica,Guarnaccia Natale,Gragnano Felice,Lombardi Raffaella,Esposito Giovanni,Bossone Eduardo,Calabrò Paolo,Losi Maria Angela,Limongelli Giuseppe

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference77 articles.

1. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

2. 2020 AHA/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the american college of cardiology/american heart association joint committee on clinical practice guidelines;Ommen;Circulation,2020

3. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults;Maron;Circulation,1995

4. New perspectives on the prevalence of hypertrophic cardiomyopathy;Semsarian;J Am Coll Cardiol,2015

5. Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy;Limongelli;Int J Cardiol,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans;Pharmacology Research & Perspectives;2024-09-10

2. An overview of the treatments for hypertrophic cardiomyopathy;Frontiers in Cardiovascular Medicine;2024-06-03

3. Evaluation of new predictive scores for sudden cardiac death in childhood hypertrophic cardiomyopathy in a French cohort;Archives of Cardiovascular Diseases;2024-06

4. Short- and Mid-Term Outcomes of Early Alcohol Septal Ablation Therapy for Patients with Mildly Symptomatic Hypertrophic Obstructive Cardiomyopathy: A Tertiary Center Experience;Journal of Clinical Medicine;2024-03-01

5. Role of Physical Therapy Intervention and Gene Therapy on Muscular Dystrophies, Current Status and Future Perspectives: A Narrative Review;Pakistan Journal of Health Sciences;2024-01-31